Biological manifestations of sarcoidosis;Manifestations biologiques au cours de la sarcoïdose

Annales de Medecine Interne

Volumn 152, Issue 1, 2001, Pages 34-38

  Bergoin, Cyrille ^a,b   Lamblin, Catherine ^c   Wallaert, Benoît ^c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c NONE

Author keywords

Bronchoalveolar lavage; Diagnosis; Monitoring; Sarcoidosis; Serological markers

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CALCIUM; CD4 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

DISEASE ACTIVITY; ENZYME BLOOD LEVEL; GRANULOMA; HYPERCALCEMIA; HYPERCALCIURIA; LEUKOCYTE COUNT; LUNG LAVAGE; LYMPHOCYTOPENIA; LYSOSOME; PATIENT MONITORING; PROGNOSIS; REVIEW; SARCOIDOSIS;

BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; HUMANS; HYPERCALCEMIA; LYMPHOPENIA; MURAMIDASE; PEPTIDYL-DIPEPTIDASE A; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY;

EID: 17144450639     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Sarcoïdose de l'adulte
2. Current concepts of pathogenesis of sarcoidosis
3. The anemia of sarcoidosis
4. Serum beta-2-microglobulin and angiotensin-converting enzyme activity in sarcoidosis
5. Beta-2-microglobulin levels in serum and bronchoalveolar lavage fluid from patients with sarcoidosis
6. Serum and bronchoalveolar level of B2-microglobulin in patients with sarcoidosis
7. Elevated serum levels of soluble interleukin-2 receptors in active pulmonary sarcoidosis: Relative specificity and association with hypercalcemia
8. Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar fluids in active sarcoidosis
9. Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis
10. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers
11. Biochemical changes in sarcoidosis
12. Elevation of serum angiotensin-converting enzyme (ACE) level in sarcoidosis
13. Angiotensin converting enzyme
14. Intérêt pratique du dosage de l'ECA sérique dans la sarcoïdose
15. The specificity and sensitivity of serum angiotensin-converting enzyme in sarcoidosis and other diseases. Experience in 12 centers in six different countries
16. Clinical findings in 715 patients with newly detected pulmonary sarcoidosis. Results of a cooperative study in former West-Germany and Switzerland
17. Serum angiotensin-converting enzyme (SACE) activity as an indicator of total body granuloma load and prognosis in sarcoidosis
18. Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosis
19. A review of angiotensin converting enzyme in health and disease
20. Serum lyzozyme levels and clinical features of sarcoidosis
21. Urinary neopterin in pulmonary sarcoidosis
22. Elevated levels of soluble ICAM-1 in serum and BAL fluid in patients with active sarcoidosis
23. Soluble intercellular adhesion molecule 1 (sICAM-1) in bronchoalveolar lavage (BAL) cell cultures and in the circulation of patients with tuberculosis, hypersensitivity pneumonitis and sarcoidosis
24. Value of ICAM-1 expression and soluble ICAM-1 level as a marker of activity in sarcoidosis
25. Statement on sarcoidosis
26. Serum level of interleukin-8 as a marker of disease activity in patients with chronic sarcoidosis
27. Activated alveolar macrophages and lymphocyte alveolitis in extra-thoracic sarcoidosis without radiological mediastinopulmonary involvement
28. Le lavage bronchoalvéolaire
29. The value of bronchoalveolar lavage in the diagnosis and pronosis of sarcoidosis
30. Bronchoalveolar lavage cell populations in diagnosis of sarcoidosis
31. Sensitivity and specificity of BAL findings in sarcoidosis
32. Predictive value of CD4/CD8 ratio in bronchoalveolar lavage in the diagnosis of sarcoidosis
33. Bronchoalveolar lavage. Still useful in diagnosing sarcoidosis?
34. CD8 alveolitis in sarcoidosis: Incidence, phenotypic characteristics, and clinical features
35. CD4/CD8 ratios in bronchoalveolar lavage fluid: Of value for diagnosing sarcoidosis?
36. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis
37. Release of superoxide anion by alveolar macrophages in pulmonary sarcoidosis
38. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung disease
39. Le syndrome de sécrétion inapproprié de calcitriol
40. Expression of CD14 correlates with lung function impairment in pulmonary sarcoidosis
41. Induced sputum in patients with sarcoidosis: Comparaison with bronchial wash and BAL
42. Serum marquers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology
43. Prognostic value of bronchoalveolar lavage lymphocyte count in recently diagnosed pulmonary sarcoidosis